Remote ischemic preconditioning did not influence 12-month survival or readmission rates in a randomized trial involving more than 5,400 patients undergoing percutaneous coronary intervention after ST-segment elevation MI.
You are here:
Most Promising’ Cardioprotective Strategy Ends Up a Bust
Submitted by: Mark Ferguson
Source: MadPage Today
Keywords:
Author(s): Nicole Lau
